Xbrane Biopharma
Invitation to presentation of Xbrane Biopharma’s interim report January – March 2024 on May 16, 2024
Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Thursday, May 16th, 2024, at 09.00 a.m. CET. Xbrane will publish the company’s interim report January – March 2024, on Thursday, May 16, 2024, at 8.00 a.m. CET.
Martin Åmark, CEO, and Anette Lindqvist, CFO/IR, will present the interim report January – March 2024, followed by a Q&A session. The presentation will be in English. To attend, please follow the link below:
If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions.
Xbrane Biopharma Q1 Report 2024 (financialhearings.com)
If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.
| Datum | 2024-05-13, kl 10:10 |
| Källa | MFN |
| Invitation to presentation of Xbrane Biopharma’s interim report January – March 2024 on May 16, 2024 |
Kopiera toppinvesterare! Med eToros innovativa CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för att använda CopyTrader-funktionen.